Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Creo Medical ( (GB:CREO) ) has shared an announcement.
Creo Medical Group PLC has announced a significant change in its shareholder structure, with M&G Plc increasing its voting rights from 5.54% to 10.12%. This acquisition of voting rights by M&G Plc, a major investment company based in London, indicates a strengthened position in Creo Medical, potentially impacting the company’s strategic decisions and signaling confidence in its market potential.
More about Creo Medical
Creo Medical Group PLC is a UK-based company operating in the medical technology industry. It specializes in the development and commercialization of minimally invasive surgical devices, focusing on advanced energy solutions for endoscopic procedures.
Average Trading Volume: 1,514,002
Technical Sentiment Signal: Sell
Current Market Cap: £49.5M
See more data about CREO stock on TipRanks’ Stock Analysis page.